journal article·2021-09

Powder X-ray diffraction of daclatasvir dihydrochloride Form N-2 (Daklinza®), C 40 H 52 N 8 O 6 Cl 2

Ryan L. Hodge, James A. Kaduk, Amy M. Gindhart, Thomas N. Blanton

Powder Diffraction· Volume 36· Issue 3
Publisher page

Abstract

The crystal structure of daclatasvir dihydrochloride Form N-2 (Daklinza®) has been refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Daclatasvir dihydrochloride, Form N-2, crystallizes in space group P 1 (#1) with a = 7.54808 (15), b = 9.5566 (5), c = 16.2641 (11) Å, α = 74.0642 (24), β = 84.0026 (13), γ = 70.6322 (5)°, V = 1064.150(11) Å 3 , and Z = 1. The hydrogen bonds were identified and quantified. Strong N–H⋯Cl hydrogen bonds link the cations and anions in chains along the a -axis. The powder pattern has been submitted to ICDD® for inclusion in the Powder Diffraction File™ (PDF®).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Crystallization and Solubility Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (11)

Show source-provided references
1. 10.1063/1.46788210.1063/1.467882 ↗
2. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
3. 10.1002/qua.2465810.1002/qua.24658 ↗
4. 10.1021/ci049780b10.1021/ci049780b ↗
5. 10.1002/jcc.2315310.1002/jcc.23153 ↗
6. 10.1017/S088571561900081210.1017/S0885715619000812 ↗
7. Sanpuhi, P. , Shfvdavkar, R. B. , Singh, G. P. , Ray, P. C. , Singh, G. P. , Sadaphal, V. A. , Rajput, L. D. , and Lande, H. M. (2018). “Crystalline forms of daclatasvir dihydrochloride,” International Patent Application WO 2018/007984 A1.
8. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
9. Kim, S. , Gao, Q. , and Yang, F. (2009) “Crystalline form of methyl ((1S)-1-(((2S)-2-(4'(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt,” International Patent Application WO 2009/020828 A1.
10. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
11. 10.1017/S088571561800082910.1017/S0885715618000829 ↗